OptimizeRx Corporation
OPRX
$5.12
$0.224.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 144.36% | 125.52% | 100.14% | 44.91% | 14.71% |
| Total Depreciation and Amortization | -0.88% | 2.06% | 4.14% | 20.84% | 43.87% |
| Total Amortization of Deferred Charges | 59.13% | 22.04% | 17.10% | 62.86% | 81.73% |
| Total Other Non-Cash Items | -56.73% | -61.75% | -71.11% | -23.46% | -19.48% |
| Change in Net Operating Assets | -701.56% | 21.61% | 83.97% | 86.03% | 94.27% |
| Cash from Operations | 116.79% | 282.80% | 854.63% | 652.47% | 231.75% |
| Capital Expenditure | 51.40% | 48.21% | 36.00% | 37.39% | -18.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 166.79% | 137.28% | -100.36% | -100.50% | -100.48% |
| Cash from Investing | 134.38% | 115.11% | 99.02% | 98.75% | 98.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -154.78% | -100.00% | -149.22% | -195.20% | -81.00% |
| Issuance of Common Stock | -- | -- | 2,153.33% | -- | -- |
| Repurchase of Common Stock | -25.87% | -26.23% | 30.15% | 40.27% | 89.18% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -124.76% | -79.15% | -123.97% | -124.64% | -117.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 157.59% | 2,215.47% | -45.30% | -68.44% | 210.36% |